Polymyxin B vs Protegrin-1 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Polymyxin B is a cyclic lipopeptide antibiotic from Bacillus polymyxa that was approved in the 1960s and fell out of favor due to nephrotoxicity, but has experienced a major clinical resurgence as a last-resort treatment for carbapenem-resistant Gram-negative infections (Acinetob...
Calculate Polymyxin B dose →Protegrin-1 (PG-1) is an 18-residue cationic beta-hairpin antimicrobial peptide isolated from porcine leukocytes. It is stabilized by two intramolecular disulfide bonds that lock its hairpin conformation....
Calculate Protegrin-1 dose →| Parameter | Polymyxin B | Protegrin-1 |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | FDA Approved | Phase 3 / Clinical |
| Half-Life | 6-8 hours | Short |
| Typical Dose | 15,000-25,000 units/kg/day IV | 0.1-1 mg/mL (topical) |
| Frequency | Every 12 hours IV | BID-TID |
| Route | IV / IM / Topical / Intrathecal | Topical / Oral rinse (research) |
| FDA Status | Approved (systemic Gram-negative infections) | Phase 3 clinical evaluation (iseganan) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.